Calendar Mesoblast Limited

Equities

MSB

AU000000MSB8

Biotechnology & Medical Research

Delayed Australian S.E. Other stock markets 05:21:20 17/02/2026 GMT			5-day change	1st Jan Change
2.410 ^AUD	-0.41%		+1.69%	-11.40%

02-13	Mesoblast Leads Global Regenerative Therapy Expansion
02-12	Mesoblast Limited Provides Data Presented at the February 2026 Tandem Meetings of the American Society for Transplantation and Cellular Therapy and the Center for Blood and Marrow Transplant Research in Salt Lake City, Utah	CI

Chart calendar Mesoblast Limited

e756817a1f.yWkL4DiB0dxZCHmXLc11LpTqCS1iJYD-vnUbomz64kY.oyh-hl3xi7sIV03lWYQxS_uGc2Aof_mn0xNW5DW2lgmWHDjVTeaSrxJxIA~13cab77dcd9e538f76de8591f7b40beb

Upcoming events on Mesoblast Limited

25/02/2026	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
01/09/2026	Q4 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
03/03/2027	Q2 2027 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
31/08/2027	Q4 2027 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on Mesoblast Limited

28/01/2026	December 2025 Sales and Revenue Release - Activities Report
04/12/2025	Piper Sandler Healthcare Conference
24/11/2025	Annual General Meeting
21/10/2025	Maxim Growth Summit
20/10/2025	September 2025 Sales and Revenue Release - Activities Report
28/08/2025	Q4 2025 Earnings Release
28/08/2025	Q4 2025 Earnings Call
18/07/2025	June 2025 Sales and Revenue Release - Activities Report
30/04/2025	March 2025 Sales and Revenue Release - Activities Report
26/02/2025	Q2 2025 Earnings Call
26/02/2025	Q2 2025 Earnings Release
19/02/2025	Emerging Growth Conference
30/01/2025	December 2024 Sales and Revenue Release - Activities Report
13/01/2025	Lytham Partners Investor Healthcare Summit
19/12/2024	Ryoncil FDA Approval Call
15/11/2024	Annual General Meeting
30/10/2024	September 2024 Sales and Revenue Release - Activities Report
16/10/2024	Maxim Healthcare Summit
04/10/2024	ShareCafe Small Cap HiddenGems Conference
29/08/2024	Q4 2024 Earnings Release

Annual results

Fiscal Period	June	2023	2024	2025	2026	2027	2028
Net sales Million AUD	Released Forecast Spread	11,6 12,8 -9.48%	8,70 11,3 -23.06%	26,4 27,6 -4.39%	177	364	709
EBITDA Million AUD	Released Forecast Spread	-89,1 -105 15.4%	-89,1 -68,9 -29.42%	-111 -64,2 -73.02%	34,8	233	625
EBIT Million AUD	Released Forecast Spread	-95,4 -112 14.7%	-96,0 -77,1 -24.62%	-121 -85,1 -42.06%	1,19	148	435
Earnings before Tax (EBT) Million AUD	Released Forecast Spread	-126 -133 4.77%	-130 -98,4 -31.99%	-156 -110 -41.97%	-20,3	107	351
Net income Million AUD	Released Forecast Spread	-126 -133 5.27%	-130 -98,2 -32.02%	-157 -110 -42.62%	-20,7	92,2	317
EPS AUD	Released Forecast Spread	-0,34 -0,17 -102.99%	-0,13 -0,08 -71.73%	-0,13 -0,08 -67.9%	-0,01	0,09	0,32
Announcement Date		30/08/23	28/08/24	28/08/25	-

Quarterly results

Fiscal Period	June	2024 Q2	2024 S1	2024 Q3	2024 Q4	2024 S2	2025 Q1	2025 Q2	2025 S1	2025 Q3	2025 Q4	2025 S2	2026 Q1	2026 Q2	2026 S1	2026 Q3	2026 Q4	2026 S2	2027 Q1	2027 Q2	2027 S1	2027 Q3	2027 Q4	2027 S2
Net sales Million AUD	Released Forecast Spread	5,22 5,76 -9.4%	5,22 5,67 -7.99%	0,00	6,61	3,71 6,14 -39.64%	2,39	2,49	4,99 4,81 3.84%	7,48	17,6	21,5 20,9 2.91%	30,7	34,8	79,2	37,6	41,8	108	62,3	65,0	113	67,9	75,6	137
EBITDA Million AUD	Released Forecast Spread		-30,6 -41,1 25.51%			-59,8 -30,0 -99.14%			-55,1 -56,8 2.99%						19,4			20,9
EBIT Million AUD	Released Forecast Spread	-27,8	-34,4 -44,2 22.21%			-63,1 -38,6 -63.59%			-58,4 -55,4 -5.43%			-64,3 -48,8 -31.62%	-14,4	-12,7	6,07	-13,5	-12,3	15,2	15,0	15,6	30,3	16,5	18,0	46,7
Earnings before Tax (EBT) Million AUD	Released Forecast Spread	-27,8	-50,3 -55,8 9.92%			-81,8 -53,4 -53.31%	-33,1	-34,6	-75,5 -71,6 -5.51%			-82,9 -54,1 -53.29%	-14,4	-12,7	-10,8	-13,5	-12,3	1,09	15,0	15,6	9,32	16,5	18,0	25,0
Net income Million AUD	Released Forecast Spread	-27,8	-50,1 -55,5 9.72%			-81,7 -53,1 -53.78%	-33,1	-34,6	-75,8 -70,8 -7.05%			-83,1 -54,0 -53.92%	-14,4	-12,7	-11,4	-13,5	-12,3	0,72	15,0	15,6	9,32	16,5	18,0	25,0
EPS AUD	Released Forecast Spread		-0,06 -0,06 6.79%			-0,08 -0,05 -39.46%		-0,06	-0,07 -0,06 -7.61%			-0,07 -0,04 -69.58%			-0,01			0,00			0,04			0,02
Announcement Date		28/02/24	28/02/24	-	-	28/08/24	-	-	26/02/25	-	-	28/08/25	-	-	-	-	-	-	-	-	-	-	-	-

Upcoming sector events for Mesoblast Limited

Today	BIOARCTIC AB	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
Today	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
18/02/2026	AMICUS THERAPEUTICS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
18/02/2026	RELAY THERAPEUTICS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
18/02/2026	INTELLIA THERAPEUTICS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
18/02/2026	KYMERA THERAPEUTICS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
18/02/2026	PRAXIS PRECISION MEDICINES, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
18/02/2026	GRAIL, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
19/02/2026	TELIX PHARMACEUTICALS LIMITED	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
23/02/2026	VIR BIOTECHNOLOGY, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format

More events

Past sector events for Mesoblast Limited

16/02/2026	BASILEA PHARMACEUTICA AG	Q4 2025 Earnings Release
12/02/2026	BRIGHT MINDS BIOSCIENCES INC.	Q1 2026 Earnings Release
12/02/2026	GNI GROUP LTD.	Q4 2025 Earnings Release
12/02/2026	TAKARA BIO INC.	Q3 2025 Earnings Release
12/02/2026	CRISPR THERAPEUTICS AG	Q4 2025 Earnings Release
11/02/2026	BLUEPRINT MEDICINES CORPORATION	Q4 2025 Earnings Release (Projected)
11/02/2026	ASCENDIS PHARMA A/S	Q4 2025 Earnings Release
10/02/2026	SUNMAX BIOTECHNOLOGY CO., LTD.	January 2026 Sales and Revenue Release
10/02/2026	POLARIS GROUP	January 2026 Sales and Revenue Release
10/02/2026	PELL BIO-MED TECHNOLOGY CO., LTD.	January 2026 Sales and Revenue Release